Skip to main content

Want a detailed portfolio tracker?

Alx Oncology (ALXO) P/E (2020 - 2026)

Alx Oncology (ALXO) P/E from Sep 30, 2020 to Jul 21, 2026. The TTM Alx Oncology (ALXO) P/E is -1.41. You can export chart.

All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.

P/E

Annual P/E change of Alx Oncology (ALXO)

YearP/EChange
2026-1.41+136.75%
2025-0.60-7.46%
2024-0.64-84.58%
2023-4.18+10.47%
2022-3.78-63.67%
2021-10.41-91.00%
2020-115.64N/A

Comparison Alx Oncology (ALXO) P/E with competitors

Alx Oncology (ALXO) P/E is -1.41.

TickerNameP/EUpside
SPRCSciSparc Ltd0.00-100.12%
NBYStablecoin Development Corp0.00-100.30%
ENLVEnlivex Ltd0.07-105.30%
FGENFibroGen Inc0.24-117.00%
CHRSCoherus Biosciences Inc0.85-160.08%
FBIOFortress Biotech Inc0.95-167.20%
ORMPOramed Pharmaceuticals Inc1.50-206.43%
AGENAgenus Inc3.01-313.10%
INVAInnoviva Inc3.15-323.33%
VXRTVaxart Inc3.55-351.35%
CRMDCorMedix Inc3.63-356.92%
CVACCureVac N.V.4.45-414.79%
GLPGGalapagos NV4.86-444.05%
SRPTSarepta Therapeutics Inc4.88-445.69%
ABEOAbeona Therapeutics Inc5.39-481.48%
ABUSArbutus Biopharma Corp5.60-496.21%
ZVRAZevra Therapeutics Inc5.89-516.86%
SPROSpero Therapeutics Inc6.23-541.02%
CGENCompugen Ltd6.31-547.08%
RIGLRigel Pharmaceuticals6.87-586.60%
SLXNSilexion Therapeutics Corp7.30-616.62%
OMEROmeros Corporation9.26-755.59%
AUPHAurinia Pharmaceuticals Inc9.58-778.69%
PLXProtalix BioTherapeutics Inc10.89-871.17%
ACADAcadia Pharmaceuticals Inc11.73-930.47%
TBPHTheravance Biopharma Inc12.26-968.26%
ADMAAdma Biologics Inc12.42-979.30%
HRMYHarmony Biosciences Holdings Inc13.82-1078.58%
SABSSAB Biotherapeutics Inc14.14-1100.96%
NAGENiagen Bioscience Inc14.82-1149.24%
INCYIncyte Corp15.82-1220.36%
REGNRegeneron Pharmaceuticals Inc15.86-1222.78%
PBYIPuma Biotechnology Inc17.32-1326.09%
CPRXCatalyst Pharmaceuticals Inc17.44-1334.84%
EXELExelixis Inc17.54-1341.83%
TGTXTG Therapeutics Inc18.97-1442.95%
MDXGMimedx Group Inc20.55-1555.28%
XOMAXOMA Royalty Corp22.87-1719.75%
ARGXArgen X SE24.30-1820.54%
CTMXCytomX Therapeutics Inc24.82-1857.58%
XOMAOXOMA Royalty Corp25.34-1894.66%
HALOHalozyme Therapeutics Inc25.62-1914.41%
XOMAPXOMA Royalty Corp25.67-1917.70%
VRTXVertex Pharmaceuticals Inc27.99-2082.30%
RPRXRoyalty Pharma plc - Class A28.69-2131.36%
SLNOSoleno Therapeutics Inc29.02-2154.57%
ASNDAscendis Pharma A/S30.09-2230.36%
LGNDLigand Pharmaceuticals Inc - Class B37.91-2784.55%
APLSApellis Pharmaceuticals Inc39.02-2863.09%
BMRNBiomarin Pharmaceutical Inc42.21-3089.02%
KRYSKrystal Biotech Inc45.34-3310.77%
ONCBeiGene Ltd69.54-5024.16%
PHARPharming Group N.V.75.03-5412.56%
TECHBio-Techne Corp101.96-7319.67%
VCELVericel Corp109.92-7883.53%
ALNYAlnylam Pharmaceuticals Inc117.96-8453.10%
GMABGenmab140.29-10033.98%
TLXTelix Pharmaceuticals Ltd162.15-11582.04%
CORTCorcept Therapeutics Inc212.86-15172.43%